Galecto Inc (GLTO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $29.78
• Market Cap: $43.73M
• EPS: $-12.11
• 52-Week High: $38.33
• 52-Week Low: $2.01

Market Sentiment

Galecto Inc currently has a Bullish sentiment score of 0.56.

About Galecto Inc

Galecto, Inc. is a clinical-stage biotechnology firm headquartered in Copenhagen, Denmark, dedicated to developing advanced therapeutic solutions for significant unmet medical needs in fibrosis, cancer, and inflammation. Leveraging its proprietary galectin technology platform, the company is strategically positioned to target critical biological pathways associated with these diseases, enhancing its potential to deliver groundbreaking treatments. With a strong pipeline of drug candidates, Gal...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Galecto Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GLTO pay dividends?

Galecto Inc (GLTO) does not currently pay a regular dividend.

What is GLTO's market cap?

Galecto Inc (GLTO) has a market capitalization of $43.73M with a current stock price of $29.78.